THC Stays in Breast Milk for Six Weeks, Study Shows

Research conducted by Children's Colorado experts and published in JAMA Pediatrics confirms the importance of abstaining from marijuana while pregnant or breastfeeding, especially considering today's more potent forms of marijuana and the drug's potential harm to infants.

Denver Business Journal Recognizes Children’s Colorado Team Member in 40 Under 40 Awards

Robert Franklin II was among The Denver Business Journal’s 40 Under 40. His work at Children’s Colorado and in the community related to diversity, health equity and inclusion earned him this recognition.

February 2021

Children’s Hospital Colorado Contributes to AFM Paper in The Lancet

Children's Colorado doctors who do research for the University of Colorado School of Medicine contributed to a paper in The Lancet about a rare polio-like disease called acute flaccid myelitis (AFM). As the first doctors to start a clinic for AFM patients, Children's specialists have deep expertise in the diagnostics and management of the condition and are committed to improving outcomes and eventually preventing it.

December 2020

Children’s Hospital Colorado Nurse Wins 2020 Nightingale Luminary Award

Amber Kerr, a coordinator and plastic surgery nurse at the Children’s Hospital Colorado Briargate Cleft Lip and Palate Program​ received the 2020 Nightingale Luminary Award​ in Clinical Advocacy.

August 2020

June 2020

Sickle Cell Partnership Recognized by Governor’s Board

The Colorado Governor’s Sickle Cell Advisory Board highlighted the quality of sickle cell disease treatment offered by the Colorado Sickle Cell Treatment and Research Center at Children’s Colorado and University of Colorado Hospital, both on the Anschutz Medical Campus, and at Children’s Colorado, Colorado Springs.

Children's Colorado Researcher Leads Study on New Standard Treatment with 95% Cure Rate for Non-Hodgkin Lymphoma

Researchers have established a new standard treatment with an improved cure rate in children with advanced B-cell non-Hodgkin lymphoma, mainly Burkitt lymphoma. A Children's Colorado researcher led the phase III international pediatric study along with international partners.